Cencora, Inc.

Fundamentals6.0
Price Action7.0
News Sentiment6.0
AI Rating
6.0

Key Drivers

  • Cash Generation
  • Margin Expansion
  • Liquidity Risk

AI
AI Summary

6.0

COR should be viewed less as a low-margin distributor and more as a specialty/services healthcare platform with strong cash generation and buyback support, but the investment case now hinges on proving that specialty mix and margin gains can offset headline revenue pressure and legal/working-capital risks.

MarginExpansion
Legal
CashFlow‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

6.0

Key Financial Insights:

  • Cash Generation
  • Margin Expansion
  • Liquidity Risk

COR is a large, cash-generative distributor with improving margins and strong interest coverage, but its case is constrained by thin profitability, heavy leverage, and weak liquidity.

cashflow
leverage

Price Behavior

7.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Higher lows
  • Breakout hold
  • Extended rally

COR has rallied over the last month, breaking above prior resistance and keeping the trend bullish, but the sharp surge into July 2 leaves it extended and at risk of a pullback if $288–$283 gives way.

breakout
momentum
Support Level: $282–$283
Resistance Level: $296.51

Sharp three-day surge into

Sentiment & News

6.0

Key News Insights:

  • Earnings Upside
  • Specialty Expansion
  • Q3 Catalyst

COR is still down nearly 18% YTD, but rising estimates, specialty-service expansion, and an upcoming earnings report suggest improving fundamentals and a near-term catalyst.

SpecialtyGrowth
EarningsWatch

The stock's near-term impact looks mixed, with strategic progress offsetting share-price weakness until the next earnings update confirms momentum